BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 38459714)

  • 21. Inactivation of
    Kukuyan AM; Sementino E; Kadariya Y; Menges CW; Cheung M; Tan Y; Cai KQ; Slifker MJ; Peri S; Klein-Szanto AJ; Rauscher FJ; Testa JR
    Cancer Res; 2019 Aug; 79(16):4113-4123. PubMed ID: 31151962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consensus Report of the 2015 Weinman International Conference on Mesothelioma.
    Carbone M; Kanodia S; Chao A; Miller A; Wali A; Weissman D; Adjei A; Baumann F; Boffetta P; Buck B; de Perrot M; Dogan AU; Gavett S; Gualtieri A; Hassan R; Hesdorffer M; Hirsch FR; Larson D; Mao W; Masten S; Pass HI; Peto J; Pira E; Steele I; Tsao A; Woodard GA; Yang H; Malik S
    J Thorac Oncol; 2016 Aug; 11(8):1246-1262. PubMed ID: 27453164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies.
    Bononi A; Napolitano A; Pass HI; Yang H; Carbone M
    Expert Rev Respir Med; 2015 Oct; 9(5):633-54. PubMed ID: 26308799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial.
    Muti P; Sacconi A; Pulito C; Orlandi G; Donzelli S; Morrone A; Jiulian J; Cox GP; Kolb M; Pond G; Kavsak P; Levine MN; Blandino G; Strano S
    J Exp Clin Cancer Res; 2022 Aug; 41(1):255. PubMed ID: 35987988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant mesothelioma in Lynch syndrome: A report of two cases and a review of the literature.
    Shih AR; Kradin RL
    Am J Ind Med; 2019 May; 62(5):448-452. PubMed ID: 31033031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-asbestos-related malignant pleural mesothelioma.
    Kanbay A; Ozer Simsek Z; Tutar N; Yılmaz I; Buyukoglan H; Canoz O; Demir R
    Intern Med; 2014; 53(17):1977-9. PubMed ID: 25175133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP.
    Dubois F; Bazille C; Levallet J; Maille E; Brosseau S; Madelaine J; Bergot E; Zalcman G; Levallet G
    Target Oncol; 2022 Jul; 17(4):407-431. PubMed ID: 35906513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
    Xu J; Kadariya Y; Cheung M; Pei J; Talarchek J; Sementino E; Tan Y; Menges CW; Cai KQ; Litwin S; Peng H; Karar J; Rauscher FJ; Testa JR
    Cancer Res; 2014 Aug; 74(16):4388-97. PubMed ID: 24928783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-7 is expressed in malignant mesothelioma and has a prognostic value.
    Mai HL; Deshayes S; Nguyen TV; Dehame V; Chéné AL; Brouard S; Blanquart C
    Mol Oncol; 2022 Oct; 16(20):3606-3619. PubMed ID: 36054746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting angiogenesis for patients with unresectable malignant pleural mesothelioma.
    Tsao A; Nakano T; Nowak AK; Popat S; Scagliotti GV; Heymach J
    Semin Oncol; 2019 Apr; 46(2):145-154. PubMed ID: 31280996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on biology and management of mesothelioma.
    Asciak R; George V; Rahman NM
    Eur Respir Rev; 2021 Mar; 30(159):. PubMed ID: 33472960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pleural mesothelioma.
    Porcel JM
    Med Clin (Barc); 2022 Sep; 159(5):240-247. PubMed ID: 35636988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
    Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
    J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung cancer and mesothelioma risks in a prospective cohort of workers with asbestos-related lung or pleural diseases.
    Taeger D; Wichert K; Lehnert M; Casjens S; Pesch B; Weber DG; Brüning T; Johnen G; Behrens T
    Am J Ind Med; 2022 Aug; 65(8):652-659. PubMed ID: 35642773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.
    Sneddon S; Patch AM; Dick IM; Kazakoff S; Pearson JV; Waddell N; Allcock RJN; Holt RA; Robinson BWS; Creaney J
    BMC Cancer; 2017 Jun; 17(1):396. PubMed ID: 28577549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene-asbestos interaction in malignant pleural mesothelioma susceptibility.
    Tunesi S; Ferrante D; Mirabelli D; Andorno S; Betti M; Fiorito G; Guarrera S; Casalone E; Neri M; Ugolini D; Bonassi S; Matullo G; Dianzani I; Magnani C
    Carcinogenesis; 2015 Oct; 36(10):1129-35. PubMed ID: 26139392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.
    Carbone M; Adusumilli PS; Alexander HR; Baas P; Bardelli F; Bononi A; Bueno R; Felley-Bosco E; Galateau-Salle F; Jablons D; Mansfield AS; Minaai M; de Perrot M; Pesavento P; Rusch V; Severson DT; Taioli E; Tsao A; Woodard G; Yang H; Zauderer MG; Pass HI
    CA Cancer J Clin; 2019 Sep; 69(5):402-429. PubMed ID: 31283845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BAP1 gene mutations in Egyptian patients with advanced sporadic malignant pleural mesothelioma (MPM): relation with clinical outcomes and survival.
    Bahnasy AA; El-Din RS; Sabri NA; Abdel-Rahman CA; Bastawisy AE
    Cancer Genet; 2018 Dec; 228-229():83-92. PubMed ID: 30553477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Italian pool of asbestos workers cohorts: mortality trends of asbestos-related neoplasms after long time since first exposure.
    Ferrante D; Chellini E; Merler E; Pavone V; Silvestri S; Miligi L; Gorini G; Bressan V; Girardi P; Ancona L; Romeo E; Luberto F; Sala O; Scarnato C; Menegozzo S; Oddone E; Tunesi S; Perticaroli P; Pettinari A; Cuccaro F; Mattioli S; Baldassarre A; Barone-Adesi F; Cena T; Legittimo P; Marinaccio A; Mirabelli D; Musti M; Pirastu R; Ranucci A; Magnani C;
    Occup Environ Med; 2017 Dec; 74(12):887-898. PubMed ID: 28775133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.
    WAGNER JC; SLEGGS CA; MARCHAND P
    Br J Ind Med; 1960 Oct; 17(4):260-71. PubMed ID: 13782506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.